Grants and Contributions:
Title:
Scaling Up A Rapid In Vitro Screening Platform for Neurotoxicity Assays to Respond to the US FDA requirements
Agreement Number:
1022273
Agreement Value:
$400,000.00
Agreement Date:
Jul 15, 2024 - Mar 29, 2025
Description:
The enterprise has developed a first-class, patent protected technology platform to produce human neuromuscular junction-on-a-chip. The technology has been validated by a leading pharmaceutical company to accelerate toxicity and efficacy tests leading to regulatory approval of two new therapeutic candidates. The FDA is collaborating to qualify this cutting-edge chip technology as a drug discovery tool to replace animal-based toxicity assays. The successful integration of the technology will directly impact drug development and toxicity testing, enhancing the FDA's regulatory processes, reviews, laboratory responses, and will significantly contribute in fortifying public health and biodefense readiness.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Laval, Quebec, CA H7V 5B7
Reference Number:
172-2024-2025-Q2-1022273
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
799217898
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 15 days. The total amended value is 100,000 dollars.
Amendment Date
Mar 6, 2025
Recipient's Operating Name:
ANANDA Devices Inc.
Recipient's Legal Name:
Ananda Devices Inc.
Federal Riding Name:
Vimy
Federal Riding Number:
24078
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54199
Amendments: